These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 36318630)

  • 21. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.
    Atyeo C; Shook LL; Nziza N; Deriso EA; Muir C; Baez AM; Lima RS; Demidkin S; Brigida S; De Guzman RM; Burns MD; Balazs AB; Fasano A; Yonker LM; Gray KJ; Alter G; Edlow AG
    Am J Obstet Gynecol; 2023 Jan; 228(1):68.e1-68.e12. PubMed ID: 35868417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
    Özgür D; Tütüncü EE
    Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
    Chu L; McPhee R; Huang W; Bennett H; Pajon R; Nestorova B; Leav B;
    Vaccine; 2021 May; 39(20):2791-2799. PubMed ID: 33707061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactogenicity of the Messenger RNA SARS-CoV-2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory Disease.
    Yang MM; Taylor KE; Paez D; Carividi A; Demissie E; Pawar N; El-Qunni AA; McMorrow LE; Schriefer RE; Huang K; Kinnett B; Klebert M; Haile A; O'Halloran JA; Presti RM; Kim W; Ellebedy AH; Ciorba MA; Paley MA; Deepak P; Kim AHJ; Katz P; Matloubian M; Nakamura M; Gensler LS
    Arthritis Care Res (Hoboken); 2022 Dec; 74(12):1953-1960. PubMed ID: 35412029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Magnus MC; Håberg SE; Carlsen EØ; Kwong JC; Buchan SA; Fell DB
    Clin Infect Dis; 2023 Jan; 76(1):57-65. PubMed ID: 36071540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines.
    Mahallawi WH; Mumena WA
    Front Immunol; 2021; 12():794642. PubMed ID: 34925378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing Antibody Responses to Messenger RNA Coronavirus Disease 2019 Vaccines Versus Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Pregnant Women and Vaccine-Induced Antibody Transfer to Infants.
    Dawood FS; Tita A; Stockwell MS; Newes-Adeyi G; Wielgosz K; Gyamfi-Bannerman C; Battarbee A; Reichle L; Thornburg N; Ellington S; Galang RR; Vorwaller K; Vargas CY; Morrill T; Parks M; Powers E; Gibson M; Varner M
    Open Forum Infect Dis; 2023 May; 10(5):ofad204. PubMed ID: 37187508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study.
    Werner F; Zeschick N; Kühlein T; Steininger P; Überla K; Kaiser I; Sebastião M; Hueber S; Warkentin L
    BMC Med; 2023 Sep; 21(1):358. PubMed ID: 37726711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are in-hospital COVID-19-related mortality and morbidity in pregnancy associated with gestational age?
    Leung C; Simões E Silva AC; Oliveira EA
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):234-242. PubMed ID: 35502537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester.
    Citu IM; Citu C; Gorun F; Sas I; Tomescu L; Neamtu R; Motoc A; Gorun OM; Burlea B; Bratosin F; Malita D
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
    Naranbhai V; Pernat CA; Gavralidis A; St Denis KJ; Lam EC; Spring LM; Isakoff SJ; Farmer JR; Zubiri L; Hobbs GS; How J; Brunner AM; Fathi AT; Peterson JL; Sakhi M; Hambelton G; Denault EN; Mortensen LJ; Perriello LA; Bruno MN; Bertaux BY; Lawless AR; Jackson MA; Niehoff E; Barabell C; Nambu CN; Nakajima E; Reinicke T; Bowes C; Berrios-Mairena CJ; Ofoman O; Kirkpatrick GE; Thierauf JC; Reynolds K; Willers H; Beltran WG; Dighe AS; Saff R; Blumenthal K; Sullivan RJ; Chen YB; Kim A; Bardia A; Balazs AB; Iafrate AJ; Gainor JF
    J Clin Oncol; 2022 Jan; 40(1):12-23. PubMed ID: 34752147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
    Siangphoe U; Baden LR; El Sahly HM; Essink B; Ali K; Berman G; Tomassini JE; Deng W; Pajon R; McPhee R; Dixit A; Das R; Miller JM; Zhou H;
    Clin Infect Dis; 2023 Jan; 76(2):271-280. PubMed ID: 36130187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals.
    Ogrič M; Žigon P; Podovšovnik E; Lakota K; Sodin-Semrl S; Rotar Ž; Čučnik S
    Front Immunol; 2022; 13():876533. PubMed ID: 35711413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.
    Gray KJ; Bordt EA; Atyeo C; Deriso E; Akinwunmi B; Young N; Baez AM; Shook LL; Cvrk D; James K; De Guzman R; Brigida S; Diouf K; Goldfarb I; Bebell LM; Yonker LM; Fasano A; Rabi SA; Elovitz MA; Alter G; Edlow AG
    Am J Obstet Gynecol; 2021 Sep; 225(3):303.e1-303.e17. PubMed ID: 33775692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy.
    St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL
    mSphere; 2024 Mar; 9(3):e0081223. PubMed ID: 38426787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.